This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Precision Genome Editing with Programmable Nucleases
Organizer(s): Jin-Soo Kim, Feng Zhang and Daniel F. Voytas
Date: January 28 - February 01, 2018
Location: Keystone Resort, Keystone, CO, USA
Sponsored by Editas Medicine, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated
Summary of Meeting:
Genome editing refers to the use of programmable DNA-targeting platforms to manipulate genetic and epigenetic information in living cells and organisms. Genome editing has been recently democratized by the development of RNA-guided endonucleases repurposed from CRISPR-Cas microbial defense systems against viruses or plasmids. Whereas novel tools such as Cpf1 and RNA-guided deaminases are being developed to expand the scope of genome editing, old tools such as ZFNs and TALENs are likely to undergo innovations as well. These tools enable genome-wide genetic screens in cell lines and genetic studies in both model and non-model organisms. Furthermore, genome editing holds great promise for broad applications in medicine and biotechnology, raising public interest and concerns. Yet genome editing is still limited by many factors such as inefficient delivery in vivo, off-target effects, and unwanted, alternative DNA repair. This conference offers opportunities to learn about new developments, advancements and applications in the field.
Scholarship Deadline: October 3 2017
Discounted Abstract Deadline: October 3 2017
Abstract Deadline: November 1 2017
Discounted Registration Deadline: December 5 2017
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Editas MedicineRegeneron Pharmaceuticals, Inc.Sangamo Therapeutics, Inc.Vertex Pharmaceuticals Incorporated
We gratefully acknowledge additional support from these exhibitors at this conference:
Agilent Technologies, Inc.Dharmacon, a Horizon Discovery Group CompanySynthego
We gratefully acknowledge additional support for this conference from:
American Society of Gene & Cell Therapy (ASGCT)Integrated DNA Technologies
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Editas Medicine
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found